Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Rein Therapeutics Inc. (RNTX) had Return on Equity of -112.86% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-5.50M |
|
-- |
|
-- |
|
$5.61M |
|
$-5.61M |
|
$0.11M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-5.50M |
|
$-5.61M |
|
$-5.61M |
|
21.92M |
|
21.92M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$8.33M |
|
$0.00M |
|
$49.30M |
|
$57.63M |
|
$5.98M |
|
-- |
|
$46.78M |
|
$52.75M |
|
$4.87M |
|
$-43.66M |
|
$4.87M |
|
22.00M |
|
| Cash Flow Statement Financials | |
$-6.17M |
|
-- |
|
$0.74M |
|
$12.87M |
|
$7.43M |
|
$-5.44M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-112.86% |
12.60% |
|
-9.55% |
|
-112.86% |
|
$0.22 |
|
$-0.28 |
|
$-0.28 |
|